Keeping the 100-year-old promise-making insulin access universal details the main barriers to accessing the lifesaving medicine, namely high prices, low availability of human insulin, a market dominated by just a few producers, and weak health systems.
Dr Paska Apiyo, the in-charge of the CTU at the facility says she is among the staff who have not paid the risk allowance yet they constantly work under stress and for long hours.
